Estrogen effects on triglyceride metabolism in analbuminemic rats

Kidney International

Volumn 57, Issue 6, 2000, Pages 2268-2274

  Shearer, Gregory C ^a,b,c,d   Joles, Jaap A ^a,b,c,d   Jones Jr , Hardin ^a,b,c,d   Walzem, Rosemary L ^a,b,c,d   Kaysen, George A ^a,b,c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c TEXAS A AND M UNIVERSITY   (United States)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Analbuminemia; Catabolism; Hepatic lipase; Lipoprotein lipase; Very low density lipoprotein

Indexed keywords

ALBUMIN; CHYLOMICRON; ESTROGEN; LIPOPROTEIN LIPASE; TESTOSTERONE; TRIACYLGLYCEROL; TYLOXAPOL; VERY LOW DENSITY LIPOPROTEIN;

ANALBUMINEMIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CASTRATION; CATABOLISM; CONTROLLED STUDY; ENZYME ACTIVITY; FATTY ACID METABOLISM; FEMALE; HYPERTRIGLYCERIDEMIA; LIPOPROTEIN METABOLISM; MALE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT;

EID: 0034074841     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00087.x     Document Type: Article

References (35)

1. 1. STAPRANS I, RAPP JH, PAN XM, ONG DL, FEINGOLD KR: Testosterone regulates metabolism of plasma chylomicrons in rats. Arteriosclerosis 10:591-596, 1990
2. 2. JOLES JA, WILLEKES-KOOLSCHIJN N, VAN TOL A, GEELHOED-MIERAS MM, DANSE LH, VAN GARDEREN E, KORTLANDT W, ERKELENS DW, KOOMANS HA: Hyperlipoproteinemia in one-year-old analbuminemic rats. Atherosclerosis 88:35-47, 1991
3. 3. TAKAHASHI M, KUSUMI K, SHUMIYA S, NAGASE S: Plasma lipid concentrations and enzyme activities in Nagase analbuminemia rats (NAR). Jikken Dobutsu 32:39-46, 1983
4. 4. JONASSON L, HANSSON GK, BONDJERS G, BENGTSSON G, OLIVECRONA T: Immunohistochemical localization of lipoprotein lipase in human adipose tissue. Atherosclerosis 51:313-326, 1984
5. 5. STAPRANS I, FELTS JM: A possible mechanism for accelerated atherogenesis in male versus female rats. Arteriosclerosis 9:224-229, 1989
6. 6. BASDEVANT A: Steroids and lipid metabolism: Mechanism of action. Int J Fertil 37(Suppl 2):93-97, 1992
7. 7. APPLEBAUM DM, GOLDBERG AP, PYKEALISTEO OJ, BRUNZELL JD, HAZZARD WR: Effect of estrogen on post-heparin lipolytic activity: Selective decline in hepatic triglyceride lipase. J Clin Invest 59:601-608, 1977
8. 8. JOLES JA, BIJLEVELD C, VAN TOL A, GEELEN MJ, KOOMANS HA: Ovariectomy decreases plasma triglyceride levels in analbuminaemic rats by lowering hepatic triglyceride secretion. Atherosclerosis 117:51-59, 1995
9. 9. JOLES JA, VAN GOOR H, VAN DER HORST ML, VAN TOL A, ELEMA JD, KOOMANS HA: High lipid levels in very low density lipoprotein and intermediate density lipoprotein may cause proteinuria and glomerulosclerosis in aging female analbuminemic rats. Lab Invest 73:912-921, 1995
10. 10. GADES MD, STERN JS, VAN GOOR H, NGUYEN D, JOHNSON PR, KAYSEN GA: Estrogen accelerates the development of renal disease in female obese Zucker rats. Kidney Int 53:130-135, 1998
11. 11. NABULSI AA, FOLSOM AR, WHITE A, PATSCH W, HEISS G, WU KK, SZKLO M: Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women: The Atherosclerosis Risk in Communities Study Investigators. (comments) N Engl J Med 328:1069-1075, 1993
12. 12. GLUECK CJ, LANG J, HAMER T, TRACY T: Severe hypertriglyceridemia and pancreatitis when estrogen replacement therapy is given to hypertriglyceridemic women. (comments) J Lab Clin Med 123: 59-64, 1994
13. 13. MOLITCH ME, OILL P, ODELL WD: Massive hyperlipemia during estrogen therapy. JAMA 227:522-525, 1974
14. 14. WALSH BW, SCHIFF I, ROSNER B, GREENBERG L, RAVNIKAR V, SACKS FM: Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. (comments) N Engl J Med 325:1196-1204, 1991
15. 15. WALSH BW, SACKS FM: Effects of low dose oral contraceptives on very low density and low density lipoprotein metabolism. J Clin Invest 91:2126-2132, 1993
16. 16. AUSTIN MA, HOKANSON JE: Epidemiology of triglycerides, small dense low-density lipoprotein, and lipoprotein a as risk factors for coronary heart disease. Med Clin North Am 78:99-115, 1994
17. 17. GRONE EF, WALLI AK, GRONE HJ, MILLER B, SEIDEL D: The role of lipids in nephrosclerosis and glomerulosclerosis. Atherosclerosis 107:1-13, 1994
18. 18. KEANE WF: Lipids and the kidney. Kidney Int 46:910-920, 1994
19. 19. JOLES JA, VAN GOOR H, BRAAM B, WILLEKES-KOOLSCHUN N, JANSEN EH, VAN TOL A, KOOMANS HA: Proteinuria, lipoproteins and renal apolipoprotein deposits in uninephrectomized female analbuminemic rats. Kidney Int 47:442-453, 1995
20. 20. KRAUSS RM, LEVY RI, FREDRICKSON DS: Selective measurement of two lipase activities in postheparin plasma from normal subjects and patients with hyperlipoproteinemia. J Clin Invest 54:1107-1124, 1974
21. 21. BOLLMAN JL, CAIN JL, GRINDLAY JA: Techniques for the collection of lymph from the liver, small intestine or thoracic duct of the rat. J Lab Clin Med 33:1349-1352, 1948
22. 22. TROUT DL, ESTES EH, FREIDBERG SJ: Titration of free fatty acids of plasma: A study of current methods and a new modification. J Lipid Res 1:199-202, 1960
23. 23. EMORI T, TAKAHASHI M, SUGIYAMA K, SHUMIYA S, NAGASE S: Age-related changes in plasma proteins of analbuminemic rats. Jikken Dobutsu 32:123-132, 1983
24. 24. KAYSEN GA, HOYE E, JONES H JR, VAN TOL A, JOLES JA: Effect of oncotic pressure on apolipoprotein A-I metabolism in the rat. Am J Kidney Dis 26:178-186, 1995
25. 25. DAVIES RW, STAPRANS I, HUTCHISON FN, KAYSEN GA: Proteinuria, not altered albumin metabolism, affects hyperlipidemia in the nephrotic rat. J Clin Invest 86:600-605, 1990
26. 26. HAFFNER SM, VALDEZ RA: Endogenous sex hormones: Impact on lipids, lipoproteins, and insulin. Am J Med 98(Suppl 1A):40S-47S, 1995
27. 27. COUCH SC, PHILIPSON EH, BENDEL RB, WIJENDRAN V, LAMMI-KEEFE CJ: Maternal and cord plasma lipid and lipoprotein concentrations in women with and without gestational diabetes mellitus: Predictors of birth weight? J Reprod Med 43:816-822, 1998
28. 28. SUGA S, TAMASAWA N, KINPARA I, MURAKAMI H, KASAI N, ONUMA T, IKEDA Y, TAKAGI A, SUDA T: Identification of homozygous lipoprotein lipase gene mutation in a woman with recurrent aggravation of hypertriglyceridaemia induced by pregnancy. J Intern Med 243:317-321, 1998
29. 29. HENDERSON H, LEISEGANG F, HASSAN F, HAYDEN M, MARAIS D: A novel glu421lys substitution in the lipoprotein lipase gene in pregnancy-induced hypertriglyceridemic pancreatitis. Clin Chim Acta 269:1-12, 1998
30. 30. BRINTON EA: Oral estrogen replacement therapy in postmenopausal women selectively raises levels and production rates of lipoprotein a-i and lowers hepatic lipase activity without lowering the fractional catabolic rate. Arterioscler Thromb Vasc Biol 16:431-440, 1996
31. 31. BJEORNTORP P: Growth hormone, insulin-like growth factor-I and lipid metabolism: Interactions with sex steroids. Horm Res 46:188-191, 1996
32. 32. NAGASE S, TAKAHASHI M: Research related to hormones in nagase analbuminemic rats. Gan To Kagaku Ryoho 14:763-770, 1987
33. 33. KRAPP A, AHLE S, KERSTING S, HUA Y, KNESER K, NIELSEN M, GLIEMANN J, BEISIEGEL U: Hepatic lipase mediates the uptake of chylomicrons and beta-VLDL into cells via the LDL receptor-related protein (LRP). J Lipid Res 37:926-936, 1996
34. 34. JOLES JA, VAN GOOR H, KOOMANS HA: Estrogen induces glomerulosclerosis in analbuminemic rats. Kidney Int 53:862-868, 1998
35. 35. SILBIGER SR, NEUGARTEN J: The impact of gender on the progression of chronic renal disease. Am J Kidney Dis 25:515-533, 1995